These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 4386795)

  • 21. [Comparative studies in the heart-lung-preparation of dog on the action spectrum of verapamil, quinidine and some alpha- and beta-sympatholytics as well as the effect of adrenaline].
    Haas H; Igarashi T
    Arzneimittelforschung; 1968 Nov; 18(11):1373-80. PubMed ID: 5755900
    [No Abstract]   [Full Text] [Related]  

  • 22. [Beta-adrenalytics and gastric, intestinal and uterine musculature. Experimental research with pronethalal, propranolol, Kö 592, MJ 1998, MJ 1999 and iproveratril].
    Marmo E; Coscia L; Magliulo S
    Farmaco Sci; 1967 Sep; 22(9):735-68. PubMed ID: 4383230
    [No Abstract]   [Full Text] [Related]  

  • 23. The possible role of an adrenergic mechanism in the antianginal action of papaverine and prenylamine.
    Szekeres L; Papp JG; Fischer E
    Eur J Pharmacol; 1967 Oct; 2(1):1-8. PubMed ID: 4384753
    [No Abstract]   [Full Text] [Related]  

  • 24. The adrenergic-receptor blocking action of verapamil.
    Dorevitch N
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):242-50. PubMed ID: 4390919
    [No Abstract]   [Full Text] [Related]  

  • 25. [Sympatholytic ("antisympathotonic") substances].
    Kruger K
    Minerva Med; 1968 Dec; 59(96):5227-30. PubMed ID: 5710726
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of the cardiac effects of several beta adrenergic blocking agents.
    Blinks JR
    Ann N Y Acad Sci; 1967 Feb; 139(3):673-85. PubMed ID: 4382727
    [No Abstract]   [Full Text] [Related]  

  • 27. [Control of myocardial metabolism by verapamil. Sites of action and therapeutic effects].
    Fleckenstein A
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1317+. PubMed ID: 5536556
    [No Abstract]   [Full Text] [Related]  

  • 28. [Interactions between beta-adrenolytic agents and narcotics. Experimental research].
    Di Mezza F; Marmo E
    Minerva Anestesiol; 1970 Mar; 36(3):184-92. PubMed ID: 4393055
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies on the mechanism of action of INPEA, iproveratril and oxyfedrin].
    Bosse JA; Schaum E
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):221-2. PubMed ID: 4390696
    [No Abstract]   [Full Text] [Related]  

  • 30. Adrenergic mechanisms in the initiation of cardiac arrhythmias.
    Garvey HL
    Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):376-90. PubMed ID: 4391896
    [No Abstract]   [Full Text] [Related]  

  • 31. [Modification of the action in vitro of bradykinin by blocking of adrenergic receptors].
    Castelli M; Baggio G; Bertolini A
    Boll Soc Ital Biol Sper; 1967 Sep; 43(18):1205-8. PubMed ID: 5624048
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of propranolol and its optical isomers on the radiocalcium uptake and the adenosine triphosphatases of skeletal and cardiac sarcoplasmic reticulum fractions (SRF).
    Scales B; McIntosh DA
    J Pharmacol Exp Ther; 1968 Apr; 160(2):261-7. PubMed ID: 4384785
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cardiac effects ofprenylamine and iproveratril in comparison with propanolol, pronethalol an ajmaline].
    Schaumann W; Bodem R; Bartsch W
    Naunyn Schmiedebergs Arch Pharmakol Exp Pathol; 1966; 255(4):328-43. PubMed ID: 4383986
    [No Abstract]   [Full Text] [Related]  

  • 34. [Differentiation between beta adrenergic and Ca 2+ antagonistic influencing components of beta receptor blockaders in the myocardium and in smooth muscles with special reference to Trasicor].
    Grün G; Byon KY; Kaufmann R; Fleckenstein A
    Arztl Forsch; 1972 Nov; 26(11):369-78. PubMed ID: 4404592
    [No Abstract]   [Full Text] [Related]  

  • 35. Is verapamil a beta-blocker?
    Grant RH; McDeritt DG; Shanks RG
    Lancet; 1968 Feb; 1(7538):362-3. PubMed ID: 4170572
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiac toxicity of -lytic drugs.
    Roba J
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:120-. PubMed ID: 4403294
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of beta adrenergic antagonists on cardiac contractions, myofibrillar ATPase activity, high-energy phosphate stores and lipid-facilitated transfort of calciumiones.
    Nayler WG; Stone J; Carson V; McInnes I; Mack V; Lowe TE
    J Pharmacol Exp Ther; 1969 Feb; 165(2):225-33. PubMed ID: 4236550
    [No Abstract]   [Full Text] [Related]  

  • 38. [Adrenergic and anti-adrenergic mechanisms of substances with anti-anginal effects].
    Palm D
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):159-67. PubMed ID: 4389904
    [No Abstract]   [Full Text] [Related]  

  • 39. On the cardiac adrenergic blocking action of iproveratril in normal and coronary-ligated dogs.
    Melville KI; Garvey HL; Shister HE
    Rev Can Biol; 1968 Sep; 27(3):225-35. PubMed ID: 5702439
    [No Abstract]   [Full Text] [Related]  

  • 40. [Beta-sympathicolytic effect of derivatives of prenylamine].
    Ehrhart G; Lindner E
    Arzneimittelforschung; 1968 Mar; 18(3):291-5. PubMed ID: 5696003
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.